NPI: 1013950807 · PALO ALTO, CA 94301 · Clinical Medical Laboratory · NPI assigned 06/13/2006
Authorized official LOPES, KRISTA controls 20+ related entities in our dataset. Read more
| Authorized Official | LOPES, KRISTA (SH VP, QUALITY, SAFETY, PATIENT EDU) |
| NPI Enumeration Date | 06/13/2006 |
Other providers sharing the same authorized official: LOPES, KRISTA
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 119,813 | $2.89M |
| 2019 | 110,638 | $2.67M |
| 2020 | 99,656 | $2.20M |
| 2021 | 139,679 | $3.34M |
| 2022 | 130,467 | $3.06M |
| 2023 | 148,189 | $3.22M |
| 2024 | 90,309 | $2.27M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 78,954 | 75,120 | $3.66M |
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 44,665 | 42,600 | $1.36M |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 15,590 | 14,629 | $1.25M |
| 99233 | Prolong inpt eval add15 m | 14,790 | 5,989 | $743K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 9,978 | 8,692 | $591K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 10,467 | 10,033 | $448K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 10,227 | 9,803 | $437K |
| 90961 | 3,107 | 3,104 | $433K | |
| 80053 | Comprehensive metabolic panel | 44,897 | 41,368 | $399K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 15,440 | 15,311 | $396K |
| 86481 | 4,224 | 4,206 | $375K | |
| 80061 | Lipid panel | 34,141 | 33,950 | $369K |
| 84443 | Thyroid stimulating hormone (TSH) | 23,597 | 23,146 | $330K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 45,487 | 40,968 | $301K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 2,177 | 2,175 | $295K |
| 99215 | Prolong outpt/office vis | 5,145 | 4,674 | $282K |
| 95004 | Percutaneous tests with allergenic extracts, immediate type reaction | 1,213 | 1,123 | $270K |
| 90960 | End-stage renal disease related services monthly, for patients 20 years and older, with 4 or more face-to-face visits | 1,728 | 1,728 | $264K |
| 83036 | Hemoglobin; glycosylated (A1C) | 33,413 | 33,171 | $258K |
| 67028 | Intravitreal injection of a pharmacologic agent | 2,150 | 2,024 | $244K |
| 86003 | 1,612 | 956 | $221K | |
| 59425 | 2,930 | 2,074 | $221K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 5,023 | 4,930 | $219K |
| 99232 | Subsequent hospital care, per day, moderate complexity | 5,888 | 2,201 | $218K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 6,216 | 6,151 | $173K |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | 3,939 | 3,912 | $166K |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | 1,380 | 517 | $165K |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | 4,606 | 4,584 | $152K |
| 99223 | Prolong inpt eval add15 m | 1,782 | 1,717 | $151K |
| 90686 | 8,850 | 8,844 | $146K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 2,126 | 2,019 | $142K |
| 87480 | 5,883 | 5,629 | $137K | |
| 87510 | 5,804 | 5,555 | $136K | |
| 87660 | 5,710 | 5,507 | $133K | |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | 813 | 807 | $128K |
| 90834 | Psychotherapy, 45 minutes with patient | 2,135 | 1,630 | $122K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 5,370 | 5,109 | $117K |
| 95117 | 9,207 | 7,067 | $117K | |
| 86803 | 6,835 | 6,760 | $116K | |
| 77063 | Screening digital breast tomosynthesis, bilateral | 3,824 | 2,087 | $114K |
| 87086 | Culture, bacterial; quantitative colony count, urine | 15,449 | 14,395 | $113K |
| 71046 | Radiologic examination, chest; 2 views | 4,891 | 4,834 | $106K |
| 93000 | 9,460 | 9,295 | $106K | |
| 80048 | Basic metabolic panel (calcium, ionized) | 17,080 | 15,946 | $101K |
| 99239 | Hospital discharge day management, more than 30 minutes | 1,850 | 1,811 | $99K |
| 82728 | 8,051 | 7,864 | $87K | |
| 99244 | Office or other outpatient consultation, moderate to high complexity | 423 | 423 | $80K |
| 0002A | 1,953 | 1,949 | $76K | |
| 90837 | Psychotherapy, 53 minutes with patient | 846 | 650 | $75K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 1,392 | 1,367 | $75K |
| 91322 | 701 | 699 | $75K | |
| 0001A | 2,005 | 2,003 | $72K | |
| 84439 | 8,104 | 7,793 | $70K | |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | 1,140 | 907 | $67K |
| 84153 | 4,082 | 3,991 | $64K | |
| 92134 | 3,691 | 3,570 | $62K | |
| 85027 | 12,181 | 11,861 | $61K | |
| 83970 | 3,016 | 2,967 | $55K | |
| 86480 | 775 | 773 | $53K | |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 5,260 | 4,380 | $53K |
| 82570 | 13,575 | 12,902 | $52K | |
| 83550 | 7,502 | 7,382 | $52K | |
| 87186 | 6,271 | 5,863 | $51K | |
| 81001 | 19,804 | 18,518 | $47K | |
| 83540 | 7,884 | 7,732 | $45K | |
| 90791 | Psychiatric diagnostic evaluation | 479 | 478 | $44K |
| J0178 | Injection, aflibercept, 1 mg | 59 | 55 | $44K |
| 80076 | 6,544 | 6,288 | $43K | |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | 837 | 810 | $43K |
| 86140 | 8,205 | 7,853 | $43K | |
| 0012A | 1,362 | 1,361 | $42K | |
| 87081 | 5,358 | 5,263 | $41K | |
| 87077 | 5,446 | 5,062 | $41K | |
| 0011A | 1,816 | 1,816 | $40K | |
| 87070 | 3,928 | 3,750 | $38K | |
| 82607 | 5,054 | 5,031 | $37K | |
| 90480 | 1,088 | 1,087 | $35K | |
| 90833 | Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) | 799 | 735 | $33K |
| J0585 | Injection, onabotulinumtoxina, 1 unit | 48 | 39 | $33K |
| 82043 | 8,795 | 8,709 | $33K | |
| 87340 | 2,728 | 2,697 | $33K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 1,679 | 1,527 | $29K |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | 165 | 107 | $28K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 307 | 307 | $27K |
| 86592 | 5,088 | 5,024 | $27K | |
| 93296 | 1,664 | 1,664 | $27K | |
| 83735 | 4,168 | 3,550 | $27K | |
| 82274 | 1,689 | 1,678 | $26K | |
| 99204 | Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 459 | 454 | $25K |
| 86765 | 1,740 | 1,730 | $25K | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | 336 | 241 | $25K |
| 82746 | 1,950 | 1,936 | $25K | |
| 86038 | 1,982 | 1,891 | $25K | |
| 80081 | 235 | 231 | $25K | |
| 86160 | 920 | 773 | $22K | |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 294 | 293 | $22K |
| 86706 | 1,641 | 1,634 | $22K | |
| 83690 | 3,170 | 3,066 | $21K | |
| 90832 | Psychotherapy, 30 minutes with patient | 475 | 381 | $20K |
| 83880 | 1,328 | 1,277 | $20K | |
| 83525 | 1,241 | 1,234 | $19K | |
| 85610 | 4,994 | 3,811 | $19K | |
| 99152 | 879 | 825 | $19K | |
| 82784 | 2,384 | 2,158 | $19K | |
| 82785 | 812 | 692 | $18K | |
| 93970 | 311 | 303 | $18K | |
| 91321 | 169 | 167 | $18K | |
| 82565 | 4,038 | 3,949 | $17K | |
| 84481 | 915 | 873 | $16K | |
| 84460 | 3,292 | 3,239 | $16K | |
| 99243 | 132 | 132 | $16K | |
| 85652 | 6,563 | 6,308 | $16K | |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 157 | 157 | $15K |
| 78815 | Positron emission tomography (PET) for limited area imaging | 18 | 12 | $15K |
| 90656 | 792 | 792 | $15K | |
| 84156 | 4,726 | 4,512 | $15K | |
| 73630 | 646 | 581 | $15K | |
| 84100 | 3,068 | 2,557 | $14K | |
| 99000 | 2,903 | 2,792 | $14K | |
| 82670 | 410 | 409 | $14K | |
| 99203 | Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 407 | 400 | $14K |
| 83516 | 983 | 955 | $13K | |
| 92557 | 463 | 463 | $13K | |
| 90962 | 120 | 120 | $13K | |
| 92550 | 1,006 | 1,004 | $13K | |
| 99254 | 177 | 167 | $13K | |
| G0108 | Diabetes outpatient self-management training services, individual, per 30 minutes | 380 | 359 | $12K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 70 | 70 | $12K |
| 84550 | 3,626 | 3,500 | $11K | |
| 0064A | 284 | 284 | $11K | |
| 86762 | 623 | 619 | $11K | |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | 162 | 161 | $10K |
| 0071A | 255 | 255 | $10K | |
| 0124A | 269 | 266 | $10K | |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | 90 | 82 | $10K |
| 82947 | 2,659 | 2,607 | $10K | |
| 99308 | Subsequent nursing facility care, per day, straightforward | 516 | 399 | $9K |
| 82533 | 550 | 519 | $9K | |
| 87400 | 852 | 744 | $9K | |
| 84450 | 1,565 | 1,526 | $9K | |
| 99238 | Hospital discharge day management, 30 minutes or less | 226 | 220 | $9K |
| 86735 | 535 | 533 | $9K | |
| 0072A | 213 | 213 | $8K | |
| 87045 | 748 | 738 | $8K | |
| 90662 | 770 | 770 | $8K | |
| 81003 | 4,050 | 3,954 | $8K | |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 63 | 63 | $8K |
| 99173 | 1,243 | 1,242 | $8K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 611 | 446 | $7K |
| 82550 | 1,497 | 1,413 | $7K | |
| 85651 | 1,718 | 1,661 | $7K | |
| 87147 | 971 | 730 | $7K | |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 98 | 95 | $7K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 211 | 185 | $7K |
| 83001 | 286 | 284 | $6K | |
| 93294 | 595 | 595 | $6K | |
| 87634 | 72 | 72 | $6K | |
| 99309 | Subsequent nursing facility care, per day, low to moderate complexity | 310 | 245 | $6K |
| 84165 | 964 | 941 | $6K | |
| 97139 | 294 | 125 | $6K | |
| 84403 | 322 | 317 | $6K | |
| 97810 | 244 | 160 | $6K | |
| 97811 | 242 | 159 | $6K | |
| 87205 | 1,468 | 1,390 | $6K | |
| 0134A | 170 | 169 | $6K | |
| 86376 | 331 | 324 | $6K | |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | 55 | 38 | $6K |
| 93750 | 81 | 25 | $5K | |
| 93015 | 93 | 85 | $5K | |
| 93248 | 195 | 195 | $5K | |
| 86364 | 427 | 424 | $5K | |
| 80069 | 1,997 | 1,822 | $5K | |
| 99205 | Prolong outpt/office vis | 133 | 132 | $5K |
| 95115 | 505 | 401 | $5K | |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | 113 | 109 | $5K |
| 87046 | 770 | 651 | $5K | |
| 93295 | 89 | 89 | $5K | |
| 85007 | 1,592 | 1,504 | $4K | |
| 84484 | 469 | 456 | $4K | |
| 86431 | 761 | 738 | $4K | |
| 80197 | 242 | 185 | $4K | |
| 86787 | 260 | 258 | $4K | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 87 | 87 | $4K |
| 86258 | 336 | 331 | $4K | |
| 92551 | 421 | 421 | $4K | |
| 0004A | 100 | 100 | $4K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 1,087 | 1,087 | $4K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 44 | 44 | $4K |
| 83615 | 584 | 487 | $4K | |
| 87088 | 525 | 515 | $4K | |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 505 | 320 | $3K |
| 95144 | 26 | 26 | $3K | |
| 90694 | 535 | 535 | $3K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 426 | 424 | $3K |
| 90792 | Psychiatric diagnostic evaluation with medical services | 26 | 26 | $3K |
| 73610 | 117 | 110 | $3K | |
| 92015 | Determination of refractive state | 275 | 273 | $3K |
| 94010 | 77 | 76 | $3K | |
| 93990 | 78 | 76 | $3K | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 422 | 414 | $3K |
| 82951 | 152 | 152 | $3K | |
| 20610 | 188 | 157 | $2K | |
| 85730 | 306 | 296 | $2K | |
| 86665 | 65 | 64 | $2K | |
| 93246 | 158 | 158 | $2K | |
| 95813 | 41 | 39 | $2K | |
| 82105 | 141 | 132 | $2K | |
| 93351 | 20 | 12 | $2K | |
| A9552 | Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 13 | 13 | $2K |
| 92567 | 98 | 98 | $2K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 159 | 147 | $2K |
| J2785 | Injection, regadenoson, 0.1 mg | 16 | 12 | $2K |
| 86704 | 135 | 135 | $2K | |
| 59025 | Fetal non-stress test | 55 | 39 | $2K |
| 82248 | 340 | 309 | $2K | |
| 90653 | 252 | 252 | $2K | |
| 76642 | 45 | 26 | $2K | |
| 81025 | 470 | 429 | $2K | |
| 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | 64 | 63 | $2K |
| 85018 | 738 | 726 | $2K | |
| 87329 | 160 | 159 | $2K | |
| 77014 | 32 | 12 | $2K | |
| 85379 | 163 | 160 | $2K | |
| 93971 | 84 | 84 | $2K | |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | 12 | 12 | $2K |
| 84146 | 68 | 67 | $2K | |
| 83721 | 139 | 139 | $2K | |
| 64483 | 13 | 12 | $1K | |
| 64615 | 13 | 13 | $1K | |
| 86664 | 64 | 64 | $1K | |
| 0031A | 34 | 34 | $1K | |
| 99310 | Prolong nursin fac eval 15m | 82 | 57 | $1K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 29 | 28 | $1K |
| 86663 | 64 | 64 | $1K | |
| 96375 | Therapeutic injection; each additional sequential IV push | 61 | 48 | $1K |
| 76937 | 192 | 173 | $1K | |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | 114 | 68 | $1K |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | 26 | 26 | $1K |
| 93793 | 193 | 160 | $1K | |
| 36415 | Collection of venous blood by venipuncture | 14,336 | 12,878 | $962.64 |
| 86225 | 56 | 56 | $904.32 | |
| 93922 | 38 | 38 | $890.39 | |
| 93325 | 113 | 81 | $885.44 | |
| 51705 | 14 | 13 | $856.43 | |
| 73030 | 72 | 60 | $847.05 | |
| 82150 | 136 | 131 | $826.68 | |
| 99222 | Initial hospital care, per day, moderate complexity | 38 | 38 | $821.38 |
| 73564 | 44 | 39 | $792.87 | |
| 0112A | 18 | 18 | $720.00 | |
| 0054A | 23 | 23 | $710.00 | |
| 0074A | 17 | 17 | $680.00 | |
| 72100 | 26 | 26 | $671.21 | |
| 86769 | 12 | 12 | $670.85 | |
| 87420 | 156 | 155 | $656.43 | |
| 87075 | 76 | 75 | $644.98 | |
| 99306 | Prolong nursin fac eval 15m | 44 | 40 | $636.21 |
| 92587 | 13 | 13 | $581.49 | |
| 84702 | 31 | 27 | $579.93 | |
| 86696 | 28 | 27 | $573.70 | |
| 0003A | 14 | 14 | $560.00 | |
| 20553 | 31 | 29 | $559.68 | |
| 83521 | 53 | 52 | $549.24 | |
| 31575 | 12 | 12 | $490.40 | |
| 87328 | 41 | 40 | $448.04 | |
| 92083 | 13 | 13 | $447.92 | |
| 84480 | 25 | 25 | $419.30 | |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | 163 | 160 | $397.64 |
| 86308 | 51 | 51 | $390.68 | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 133 | 105 | $383.56 |
| 86334 | 25 | 25 | $375.89 | |
| 96127 | 51 | 51 | $370.52 | |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 12 | 12 | $362.89 |
| 82627 | 12 | 12 | $349.37 | |
| 82977 | 38 | 37 | $332.59 | |
| 95251 | 13 | 13 | $330.21 | |
| 0296T | 24 | 24 | $327.61 | |
| 0298T | 36 | 36 | $312.32 | |
| 86200 | 38 | 38 | $302.70 | |
| 85045 | 107 | 105 | $300.98 | |
| 99429 | 12 | 12 | $300.00 | |
| 92579 | 13 | 12 | $292.44 | |
| 90670 | 15 | 15 | $270.00 | |
| 81015 | 88 | 87 | $247.90 | |
| J7050 | Infusion, normal saline solution, 250 cc | 70 | 64 | $226.28 |
| 82950 | 38 | 37 | $222.45 | |
| 86695 | 13 | 12 | $214.15 | |
| 94060 | 12 | 12 | $213.12 | |
| 84132 | 156 | 147 | $207.26 | |
| 92133 | 12 | 12 | $199.16 | |
| 93298 | 12 | 12 | $196.12 | |
| 99307 | 72 | 72 | $191.64 | |
| J1030 | Injection, methylprednisolone acetate, 40 mg | 38 | 38 | $190.78 |
| 77080 | 29 | 29 | $186.77 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 16 | 15 | $151.55 |
| 87493 | 12 | 12 | $143.27 | |
| 83655 | 30 | 29 | $135.04 | |
| 87324 | 12 | 12 | $113.05 | |
| 87206 | 14 | 13 | $103.86 | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 53 | 53 | $96.35 |
| 97014 | 27 | 12 | $69.53 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 45 | 36 | $61.61 |
| 82330 | 28 | 27 | $60.84 | |
| G0500 | Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intra-service time; patient age 5 years or older (additional time may be reported with 99153, as appropriate) | 28 | 28 | $36.12 |
| 90785 | 43 | 39 | $3.88 | |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | 13 | 12 | $0.74 |
| G0008 | Administration of influenza virus vaccine | 797 | 797 | $0.00 |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 52 | 52 | $0.00 |
| G0009 | Administration of pneumococcal vaccine | 50 | 50 | $0.00 |
| 93307 | 12 | 12 | $0.00 |